These studies reported that inhibiting HPSE reduced disease scores as well as the infiltration of immune cells into the central nervous system (CNS), suggesting that HPSE inhibition is a promising therapeutic strategy for MS [17, 18]. Here, HPSE is linked to myeloid sarcoma.